Abstract
Sympathetic nervous system over-activity is closely linked with elevation of systemic blood pressure. Both animal and human studies suggest renal sympathetic nerves play an important role in this respect. Historically, modulation of sympathetic activity has been used to treat hypertension. More recently, catheter based renal sympathetic denervation was introduced for the management of treatment resistant hypertension. Sound physiological principles and surgical precedent underpin renal denervation as a therapy for treatment of resistant hypertension. Encouraging results of early studies led to a widespread adoption of the procedure for management of this condition. Subsequently a sham controlled randomised controlled study failed to confirm the benefit of renal denervation leading to a halt in its use in most countries in the world. However, critical analysis of the sham-controlled study indicates a number of flaws. A number of lessons have been learnt from this and other studies which need to be applied in future trials to ascertain the actual role of renal denervation in the management of treatment resistant hypertension before further implementation. This chapter deals with all these issues in detail.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abboud FM (1974) Effects of sodium, angiotensin, and steroids on vascular reactivity in man. Fed Proc 33:143–149
Azizi M, Sapoval M, Gosse P, Monge M, Bobrie G, Delsart P et al (2015) Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial. The Lancet 385(9981):1957–1965
Bhatt DL, Kandzari DE, O’Neill WW, D’Agostino R, Flack JM, Katzen BT et al (2014) A controlled trial of renal denervation for resistant hypertension. N Engl J Med 370(15):1393–1401
Böhm M, Mahfoud F, Ukena C, Hoppe UC, Narkiewicz K, Negoita M et al (2015) First report of the global SYMPLICITY registry on the effect of renal artery denervation in patients with uncontrolled hypertension. Hypertension 65(4):766–774
Brinton T, Anderson T, Zhang J, Gertner M (2011) Ultrasound mediated renal sympathetic denervation. Circulation 124:A12272 (Abstract)
Chapleau MW, Hajduczok G, Abboud FM (1988) Mechanisms of resetting of arterial baroreceptors: an overview. Am J Med Sci 295:327–334
Cullen-McEwen LA, Kett MM, Dowling J, Anderson WP, Bertram JF (2003) Nephron number, renal function, and arterial pressure in aged GDNF heterozygous mice. Hypertension 41:335–340
Dahal K, Kunwar S, Rijal J, Alqatahni F, Panta R, Ishak N et al (2015) The effects of aldosterone antagonists in patients with resistant hypertension: a meta-analysis of randomized and nonrandomized studies. Am J Hypertens 28(11):1376–1385
Davis MI, Filion KB, Zhang D, Eisenberg MJ, Afilalo J, Schiffrin EL et al (2013) Effectiveness of renal denervation therapy for resistant hypertension: a systematic review and meta-analysis. J Am Coll Cardiol 62(3):231–241
DiBona GF, Kopp UC (1995) Neural control of renal function: role in human hypertension. In: Laragh JH, Brenner BM (eds) Hypertension: pathophysiology, diagnosis, and management, 2nd edn. Raven, New York, pp 1349–1358
DiBona GF, Kopp UC (1997) Neural control of renal function. Physiol Rev 77:75–197
DiBona GF, Sawin LL (1999) Functional significance of the pattern of renal sympathetic nerve activation. Am J Physiol 277:R346–R353
Dorr O, Liebetrau C, Mollmann H, Gaede L, Troidl C, Rixe J et al (2014) Soluble fms-like tyrosine kinase-1 and endothelial adhesion molecules (intercellular cell adhesion molecule-1 and vascular cell adhesion molecule-1) as predictive markers for blood pressure reduction after renal sympathetic denervation. Hypertension 63(5):984–990
Esler M (2000) The sympathetic system and hypertension. Am J Hypertens 13:99S–105S
Esler M, Jennings G, Korner P, Blombery P, Sacharias N, Leonard P (1984a) Measurement of total and organ-specific norepinephrine kinetics in humans. Am J Physiol 247:E21–E28
Esler M, Jennings G, Leonard P, Sacharias N, Burke F, Johns J et al (1984b) Contribution of individual organs to total noradrenaline release in humans. Acta Physiol Scand Suppl 527:11–16
Esler M, Lambert G, Brunner-La Rocca HP, Vaddadi G, Kaye D (2003) Sympathetic nerve activity and neurotransmitter release in humans: translation from pathophysiology into clinical practice. Acta Physiol Scand 177(3):275–284
Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Böhm M (2010) Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. The Lancet 376(9756):1903–9
Freis ED (1990) Origins and development of antihypertensive treatment. In: Laragh JH, Brenner BM (eds) Hypertension: pathophysiology, diagnosis, and management, 2nd edn. Raven, New York, pp 2093–2094
Freis ED (1995) Historical development of antihypertensive treatment. In: Laragh JH, Brenner BM (eds) Hypertension: pathophysiology, diagnosis, and management, 2nd edn. Raven, New York, pp 2741–2751
Gattone VH, Evan AP, Overhage JM, Severs WB (1990) Developing renal innervation in the spontaneously hypertensive rat: evidence for a role of the sympathetic nervous system in renal damage. J Hypertens 8:423–428
Grassi G, Giannattasio C, Failla M, Pesenti A, Peretti G, Marinoni E et al (1995) Sympathetic modulation of radial artery compliance in congestive heart failure. Hypertension 26(2):348–354
Grassi G, Colombo M, Seravalle G, Spaziani D, Mancia G (1998) Dissociation between muscle and skin sympathetic nerve activity in essential hypertension, obesity, and congestive heart failure. Hypertension 31(1):64–67
Grisk O, Rose H-J, Lorenz G, Rettig R (2002) Sympathetic – renal interaction in chronic arterial pressure control. Am J Physiol Regul Integr Comp Physiol 283:R441–R450
Guo GB, Thames MD, Abboud FM (1983) Arterial baroreflexes in renal hypertensive rabbits. Selectivity and redundancy of baroreceptor influence on heart rate, vascular resistance, and lumbar sympathetic nerve activity. Circ Res 53:223–234
Hameed MA, Tebbit L, Jacques N, Thomas M, Dasgupta I (2016) Non-adherence to antihypertensive medication is very common among resistant hypertensives: results of a directly observed therapy clinic. J Hum Hypertens 30(2):83–9
Head RJ (1989) Hypernoradrenergic innervation: its relationship to functional and hyperplastic changes in the vasculature of the spontaneously hypertensive rat. Blood Vessels 26:1–20
Heran BS, Galm BP, Wright JM (2012) Blood pressure lowering efficacy of alpha blockers for primary hypertension. Cochrane Database Syst Rev 15(8):CD004643. doi:10.1002/14651858.CD004643.pub3
Johansson M, Rundqvist B, Petersson M, Lambert G, Friberg P (2003) Regional norepinephrine spillover in response to angiotensin-converting enzyme inhibition in healthy subjects. J Hypertens 21:1371–1375
Jung O, Gechter JL, Wunder C, Paulke A, Bartel C, Geiger H et al (2013) Resistant hypertension? Assessment of adherence by toxicological urine analysis. J Hypertens 31(4):766–774
Kandzari DE, Bhatt DL, Brar S, Devireddy CM, Esler M, Fahy M et al (2015) Predictors of blood pressure response in the SYMPLICITY HTN-3 trial. Eur Heart J 36(4):219–227
Kim JR, Kiefe CI, Liu K, Williams OD, Jacobs DR Jr, Oberman A (1999) Heart rate and subsequent blood pressure in young adults: the CARDIA study. Hypertension 33(2):640–646
Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K et al (2009) Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. The Lancet 373(9671):1275–1281
Krum H, Schlaich MP, Sobotka PA, Böhm M, Mahfoud F, Rocha-Singh K et al (2014) Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study. The Lancet 383(9917):622–629
Lawson AJ, Shipman KE, George S, Dasgupta I (2016) A novel ‘dilute-and-shoot’ liquid chromatography-tandem mass spectrometry method for the screening of antihypertensive drugs in urine. J Anal Toxicol 40(1):17–27
Li Z, Mao HZ, Abboud FM, Chapleau MW (1996) Oxygen-derived free radicals contribute to baroreceptor dysfunction in atherosclerotic rabbits. Circ Res 79:802–811
Lobo MD, de Belder MA, Cleveland T, Collier D, Dasgupta I, Deanfield J et al (2015a) Joint UK societies’ 2014 consensus statement on renal denervation for resistant hypertension. Heart 101:10–16. doi:10.1136/heartjnl-2014-307029
Lobo M, Saxena M, Jain AJ, Walters D, Pincus M, Montarello J et al (2015b) 4a.09: safety and performance of the enlightn renal denervation system in patients with severe uncontrolled hypertension: 12 month results from the Enlightn Ii Study. J Hypertens 33(Suppl 1):e51
Lyons RH, Moe GK, Neligh RM, Hoobler SW, Campbell KN, Berry RL et al (1947) The effects of blockade of the autonomic ganglia in man with tetraethylammonium; preliminary observations on its clinical application. Am J Med Sci 213:315–323
Marcus R, Krause L, Weder AB, Dominguez-Meja A, Schork NJ, Julius S (1994) Sex-specific determinants of increased left ventricular mass in the Tecumseh Blood Pressure Study. Circulation 90(2):928–936
Mark AL (1996) The sympathetic nervous system in hypertension: a potential long-term regulator of arterial pressure. J Hypertens Suppl 14(5):S159–65
Nash DT (1990) Alpha-adrenergic blockers: mechanism of action, blood pressure control, and effects of lipoprotein metabolism. Clin Cardiol 13:764–772
Neuzil P, Whitbourn R, Starek Z, Esler M, Brinton T, Gertner M (2013) Optimized external focused ultrasound for renal sympathetic denervation – wave II trial. J Am Coll Cardiol 62(18_S1):B20–B20 (Abstract)
O’Brien E, Parati G, Stergiou G, Asmar R, Beilin L, Bilo G et al (2013) European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens 31(9):1731–1768
Oates JA, Gillespie L Jr, Udenfiiend S, Sjoerdsma A (1960) Decarboxylase inhibition and blood pressure reduction by alpha-methyl-3,4-dihydroxy-DL-phenylalanine. Science 131:1890–1891
Oparil S, Zaman MA, Calhoun DA (2003) Pathogenesis of hypertension. Ann Intern Med 139(9):761–776
Ormiston J et al (2014) Non-invasive renal denervation using externally delivered focused ultrasound: early experience using Doppler-based image targeting and tracking for treatment. J Am Coll Cardiol 64/11(Suppl B): TCT–412. (Abstract)
Paton WDM, Zaimis EJ (1948) Clinical potentialities of certain bisquaternary salts causing neuromuscular and ganglionic block. Nature 162:810
Peet MM (1947) Results of bilateral supradiaphragmatic splanchnicectomy for arterial hypertension. N Engl J Med 236:270–276
Prichard BN, Gillam PM (1964) Use of propranolol (Inderal) in treatment of hypertension. Br Med J 2:725–732
Rosa J, Zelinka T, Petrak O, Strauch B, Somloova Z, Indra T et al (2014) Importance of thorough investigation of resistant hypertension before renal denervation: should compliance to treatment be evaluated systematically? J Hum Hypertens 28(11):684–688
Rosa J, Widimský P, Toušek P, Petrák O, Curila K, Waldauf P et al (2015) Randomized comparison of renal denervation versus intensified pharmacotherapy including spironolactone in true-resistant hypertension: six-month results from the Prague-15 study. Hypertension 65(2):407–413
Sainio K, Suvanto P, Davies J, Wartiovaara J, Wartiovaara K, Saarma M et al (1997) Glial-cell-line-derived neurotrophic factor is required for bud initiation from ureteric epithelium. Development 124:4077–4087
Sakakura K, Ladich E, Cheng Q, Otsuka F, Yahagi K, Fowler DR et al (2014) Anatomic assessment of sympathetic peri-arterial renal nerves in man. J Am Coll Cardiol 64(7):635–643
Schlaich MP, Sobotka PA, Krum H, Lambert E, Esler MD (2009) Renal sympathetic-nerve ablation for uncontrolled hypertension. N Engl J Med 361(9):932–934
Scislo TJ, Augustyniak RA, O’Leary DS (1998) Differential arterial baroreflex regulation of renal, lumbar, and adrenal sympathetic nerve activity in the rat. Am J Physiol 275:R995–R1002
Sharp AS, Davies JE, Lobo MD, Bent CL, Mark PB, Burchell AE et al (2016) Renal artery sympathetic denervation: observations from the UK experience. Clin Res Cardiol:1–9. doi:10.1007/s00392-015-0959-4
Smithwick RH, Thompson JE (1953) Splanchnicectomy for essential hypertension; results in 1,266 cases. JAMA 152:1501–1504
Stella A, Zancetti A (1991) Role of renal affarents. Physiological Reviews 71(3):659–682
Thomas P, Dasgupta I (2015) The role of the kidney and the sympathetic nervous system in hypertension. Paediatric Nephrology 30(4):549–60. doi:10.1007/s00467-014-2789-4
Tomaszewski M, White C, Patel P, Masca N, Damani R, Hepworth J et al (2014) High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysis. Heart 100:855–61
Vallbo AB, Hagbarth KE, Torebjork HE, Wallin BG (1979) Somatosensory, proprioceptive, and sympathetic activity in human peripheral nerves. Physiol Rev 59:919–957
Warren RE, Marshall T, Padfield PL, Chrubasik S (2010) Variability of office, 24-hour ambulatory, and self-monitored blood pressure measurements. Br J Gen Pract 60(578):675–680
Williams B, MacDonald TM, Morant S, Webb DJ, Sever P, McInnes G et al (2015) Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial. The Lancet 386(10008):2059–2068
Worthley SG, Tsioufis CP, Worthley MI, Sinhal A, Chew DP, Meredith IT et al (2013) Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension: the EnligHTN I trial. Eur Heart J 34(28):2132–2140
Worthley SG, Wilkins GT, Webster MW, Montarello JK, Antonis PR, Whitbourn RJ, et al (2015) Safety and performance of the next generation EnligHTN™ renal denervation system in patients with drug-resistant, uncontrolled hypertension: The EnligHTN III first-in-human multicentre study. Clin Trials Reg Sci Cardiol 8(8):4–10
Xie PL, Chapleau MW, McDowell TS, Hajduczok G, Abboud FM (1990) Mechanism of decreased baroreceptor activity in chronic hypertensive rabbits. Role of endogenous prostanoids. J Clin Invest 86:625–630
Yamada Y, Miyajima E, Tochikubo O, Matsukawa T, Ishii M (1989) Age-related changes in muscle sympathetic nerve activity in essential hypertension. Hypertension 13(6 Pt 2):870–877
Zazgornik J, Biesenbach G, Janko O, Gross C, Mair R, Brücke P et al (1998) Bilateral nephrectomy: the best, but often overlooked, treatment for refractory hypertension in hemodialysis patients. J Am Hypertens 11:1364–1370
Zuern CS, Eick C, Rizas KD, Bauer S, Langer H, Gawaz M et al (2013) Impaired cardiac baroreflex sensitivity predicts response to renal sympathetic denervation in patients with resistant hypertension. J Am Coll Cardiol 62(22):2124–30
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing AG
About this chapter
Cite this chapter
Hameed, M.A., Dasgupta, I. (2016). Renal Denervation. In: Islam, M.S. (eds) Hypertension: from basic research to clinical practice. Advances in Experimental Medicine and Biology(), vol 956. Springer, Cham. https://doi.org/10.1007/5584_2016_148
Download citation
DOI: https://doi.org/10.1007/5584_2016_148
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-44250-1
Online ISBN: 978-3-319-44251-8
eBook Packages: MedicineMedicine (R0)